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1. Introduction 
Researches concerning probiotics were initiated by a Russian scientist named Elie 
Metchnikoff. He emphasized the importance of Lactobacillus species and fermented milk 
products present in the gastrointestinal tract for a healthy and long life. The term 
"probiotics" was first introduced in 1953 by Werner Kollath, and he defined probiotics as 
microbially derived factors that stimulate the growth of other microorganisms. Afterwards, 
the term “probiotics” was defined by Roy Fuller in 1989 as a live microbial feed supplement 
which beneficially affects the host by improving its intestinal microbial balance. Fuller's 
definition emphasizes the requirement of viability for probiotics and introduces the aspect 
of a beneficial effect on the host. Although, this definition has been widely used by the 
entire scientific world, according to the currently adopted definition by FAO/WHO, 
probiotics are: "Live microorganisms confer a health benefit on the host when administered 
in adequate amounts” (FAO/WHO, 2001). 
The most frequently used probiotic microorganisms are Lactobacillus and Bifidobacterium 
species. However, there are also much more bacteria and some yeast species used as 
probiotic. Bacteria and yeast species, which are used commonly as probiotic, are listed by 
Heyman & Menard (2002) as below. Lactobacillus species: L. acidophilus, L. rhamnosus, L. 
gasseri, L. reuteri, L. bulgaricus, L plantarum, L. johnsonii, L. paracasei, L. casei, L. salivarius, L. 
lactis. Bifidobacterium species: B. bifidum, B. longum, B. breve, B. infantis, B. lactis, B. adolescentis. 
Other species: Streptococcus thermophilus, Escherichia coli, Bacillus cereus, Clostridium 
butyricum, Enterococcus faecalis, Enterococcus faecium. Yeast: Saccharomyces boulardii, 
Saccharomyces cerevisiae, VSL#3 (four strains of lactobacilli, three strains of bifidobacteria, 
one strain of Streptococcus salivarius sp. thermophilus). 
There is a mutual interaction between intestinal cells and microorganisms present in the 
gastrointestinal tract. Commensal microorganisms in the gastrointestinal tract have 
multidirectional effects on digestion, absorption and barrier function, secretory functions, or 
postnatal maturation of intestinal mucosa. Furthermore, it has been known that they change 
gene expression in intestinal cells (Hooper et al., 2001). The changes in the function of 
intestinal tract (e.g. the increase of motility, or disruption of carbohydrate digestion) also 
affect bacteria population and colonization. 
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Probiotics are widely used for the promotion and improvement of health in humans and in 
animal species. Probiotics have been used as a biologically active substance in a large extend 
of pathologic conditions ranging from antibiotic-associated or travelers’  diarrhea, irritable 
bowel syndrome (IBS), and lactose intolerance to dental caries, ulcers due to Helicobacter 
pylori, hepatic encephalopathy, intestinal motility disorders and neonatal necrotizing 
enterocolitis (Deshpande et al., 2011). It has been used as a growth, or production 
performance promoter in poultry species or farm animals. There are also numerous 
scientific reports about the interaction between probiotics and immune system. On the other 
hand, the effects of probiotics on digestive physiology and intestinal tract morphology have 
not been documented sufficiently. Therefore, the objective of this chapter is to assess the 
effects of probiotics on gastrointestinal physiology and morphology in human and animal 
models. The effects of probiotics on digestive and absorptive function of the intestine, 
expression of brush border enzymes and nutrient transport systems have been investigated 
in this chapter. The relationship between probiotics and gut motility or transit time of 
gastrointestinal content has also been highlighted. The effects of probiotics on 
morphological characteristics and the proliferation capacity of crypt and villus epithelium 
have been focused and in addition, the effects of probiotic on enteric nervous system have 
been evaluated. Finally, impact of the probiotics on the physical and functional barrier of 
gastrointestinal tract has been evaluated in this chapter.  
2. The effects of probiotics on intestinal morphology and cell proliferation 
To investigate the effects of microorganisms on the development of digestive tract, generally 
animal models are used. Because, obtaining and examining intestinal mucosal samples of 
people are technically more difficult. The morphological parameters such as length of villi, 
depth of crypt, villi/crypt proportion, and surface area of villi are used to investigate the 
effects of microorganisms on intestinal morphology and cell proliferation. The height of villi 
and the depth of crypt are considered as the indicators of intestinal functions.  
In the comparative studies conducted on germ free and conventional animals it has been 
determined that microorganisms located to digestive tract during the postnatal period 
caused to decreased villi length and increased crypt depth in conventional animals i.e. in pig 
(Willing & Van Kessel, 2007), in rat (Ishikawa et al., 1999) and in birds (Furuse & Okumura, 
1994). However, it has been also reported that there is no difference between germ-free and 
conventional animals regarding development of villi (Sharma et al., 1995). It has been 
determined that length of villi is higher in gnotobiotic animal models as in germ-free 
animals compared to conventional animals (Herich et al., 2004). The effects of probiotics 
have been investigated by inoculating probiotics to germ free animals or supplementing 
conventional animals with probiotics. 
2.1 Villus height 
Willing & Van Kessel (2007) have reported that villus height was increased in gnotobiotic 
piglets inoculated Lactobacillus fermentum (monoassociated with Lactobacillus fermentum) and 
Di Giancamillo et al. (2008) also has reported increase in villus height in piglets 
supplemented with Pediococcus acidilactici. Yang et al. (2009) have investigated intestinal 
tract morphology of mice supplemented orally high, low and moderate doses of 
Bifidobacterium adolescentis BBMN23 and Bifidobacterium adolescentis BBMN68 after 2 and 4 
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weeks of application. Villus height was longer in low dose group compared to those of 
controls, but moderate and high doses did not affect it after two weeks. However after 4 
weeks, villus height increased in all groups supplemented with probiotic. Similarly villus 
height increase has been reported in studies conducted on birds as an animal model (Samli 
et al., 2007; Awad et al., 2010).  
Effects of the probiotic on villus height may change depending on the species of 
microorganism or probiotic. For example, villus height in duodenum and ileum increased 
but did not changed in jejunum of broiler chicks supplemented with Pediococcus acidlactici as 
probiotic (Taheri et al., 2010). On the other hand Günal et al. (2006) reported that villus 
height of jejunum and ileum increased in broiler chicks applied multi-microbe probiotic 
product. Segmental differences were also found in comparative studies conducted on germ 
free and conventional animals. Shirkey et al. (2006) have reported that villus height was the 
longest in jejunum of pigs supplemented with Lactobacillus fermentum. On the other hand 
Shurson et al. (1990) reported that germ-free pigs had longer ileal and duodenal villi, but 
shorter jejunal villi compared with their conventional counterparts. Saccharomyces boulardii is 
one of the yeast that has been using as probiotic. It has been determined that there was no 
significance change in villus height or crypt depth of intestinal biopsy samples obtained 
from volunteers who were supplemented with Saccharomyces boulardii for 14 days (Buts et 
al., 2002). However, another yeast species (Saccharomyces cerevisiae) was reported to 
increased villus height of ileum in birds (Zhang et al., 2005). Meslin and Sacquet (1984) who 
investigated microvilli on the surface of enterocytes reported that the microvilli were 
significantly shorter in all small intestinal regions when the micro flora was present. The 
decrease in microvillus length (due to the presence of micro flora) in germ free rat, was 5% 
in the duodenum, 9% in the jejunum and 18% in the ileum. Because increased villus height 
leads to increased surface area at the same time, digestion and absorption of disaccharides 
and dipeptides are promoted. In addition, it was indicated that longer villi are correlated 
with activation of cell mitosis (Samanya & Yamauchy, 2002). 
2.2 Crypt depth 
The data related to effects of probiotics on crypt depth are inconsistent. Probably there are 
variations depending on the species, the dose or the application of used probiotic. Yang et 
al. (2009) have reported that crypt depth decreased in mice supplemented with moderate 
and high doses of probiotic (Bifidobacterium adolescentis BBMN23) for 2 weeks, but on the 
contrary it was increased in low dose probiotic supplemented group compared to controls. 
However after 4 weeks of application, increased crypt depth has been reported in moderate 
and high doses groups. Willing & Van Kessel (2007) have reported that crypt depth was 
increased in piglets inoculated with Lactobacillus fermentum (monoassociated with 
Lactobacillus fermentum) compared to conventional animals. Similarly, increased crypt depth 
in duodenum, jejunum and ileum of chicks supplemented with Bacillus subtilis has been 
found (Pelicano et al., 2005).  
Scharek et al. (2005) have reported that there was no significant change in the crypt depth in 
proximal jejunum of pigs supplemented with Enterococcus faecium 68. Similarly, it has been 
stated that crypt depth didn’t change in duodenum, but decreased in ileum of broiler chicks 
supplemented with Lactobacillus sp (Awad et al., 2009). In addition, it has been reported that 
crypt depth was not changed in broiler chicks supplemented with Saccharomyces cerevisiae 
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yeast (Zhang et al., 2005). Increased crypt depth indicates that both mucosal secretion 
(Chiou et al., 1996) and cell turnover are high (Yason et al., 1987).  
2.3 Villus height/crypt depth ratio 
In studies conducted on germ free animals it has been determined that the villus 
height/crypt depth ratio is higher in germ free animals than conventional animals 
(Heneghan et al., 1984). Awad et al. (2010) have reported that villus height to crypt depth 
ratio increased in duodenum and ileum of chicks supplemented with Lactobacillus sp. 
Similarly, supplementation of multi-microbe probiotic product has been reported to cause 
increased villus height to crypt depth ratio in duodenum and ileum (Kim et al., 2011). It has 
been indicated that, increased villus height to crypt depth ratio are directly correlated with 
an increased epithelial turnover (Fan et al., 1997). Therefore, it may be concluded that 
bacteria used as probiotic positively affect development of intestinal epithelia.  
2.4 Villus surface area 
The effects of probiotics on villus surface area may change depending on the segment which 
bacteria colonized. For example, jejunum villus surface area increased, but duodenum or 
ileum surface area did not affected in chicks supplemented with probiotic containing 
Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, and Enterococcus faecium 
species (Smirnov et al., 2005). Similarly Samanya and Yamauchy (2002) have reported that 
Bacillus subtilis natto increased villus surface dose dependently but this increase varied 
between different segments. Increased surface area allows for increased intestinal absorptive 
area. Increased absorptive area is useful because digested nutrients pass into the villi 
through diffusion, so effectiveness of diffusion increases. 
2.5 Cell proliferation, migration and turnover 
Proliferation, migration, number and apoptosis of cells in intestinal tract are affected by 
secreted molecules or fermented products of microorganisms in digestive tract.  
It has been determined that cell count and mitotic index in intestinal villus and crypt was 
higher in gnotobiotic rats mono-associated with Lactobacillus rhamnousus GG compared to 
germ-free or conventional animals (Banasaz et al., 2002). Probiotics both increase cells in 
intestinal mucosa and affect the migration of cells in crypt to the tip of villus. Canonici et al. 
(2011) have revealed by in vitro and in vivo studies that Saccharomyces boulardii accelerates 
migration of intestinal enterocytes through crypt-villus axis by activating ǂ2ǃ1 integrin 
collagen receptor. Because of this effect, Saccharomyces boulardii accelerates the repair of 
intestinal epithelium damage.  
Results related to the effects of probiotics on the proliferation of intestinal epithelium cells 
are controversial. Mogilner et al. (2007) have reported that Lactobacillus GG’ did not affect 
proliferation of enterocytes in rats with short bowel syndrome. Similarly, it has been 
reported that Saccharomyces boulardii did not affect proliferation of enterocytes (Canonici et 
al., 2011). However Ichikawa et al. (1999) have suggested that Clostridium butyricum and 
Lactobacillus casei had tropic effect on digestive tract by enhancing proliferation of intestinal 
epithelial cells. It has been reported that probiotics increased the production of short-chain 
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fatty acids (SCFA) (Sakata et al., 1999). Investigators have suggested that proliferative effects 
of probiotics on intestinal epithelial cells are based on the probiotic induced increased SCFA 
production. In the same way, Di Giancamillo et al. (2008) have reported that enterocyte 
proliferation increased in piglets supplemented with Pediococcus acidilactici. 
Mogilner et al. (2007) have reported that there was a decrease in enterocyte death via 
apoptosis in rats with short bowel syndrome supplemented with Lactobacillus GG. 
It has been suggested that bacteria used as probiotic affect functions and counts of the goblet 
cells in intestinal mucosa other than enterocytes. Because the mucus secreted by goblet cells 
is one of the factors composing intestinal barrier, it has significance on the prevention of 
pathogen invasion in digestive tract.  
Gauffin Cano et al. (2002) reported an increase in the number of goblet cells after the 
administration of the probiotic strain Lactobacillus casei CRL 431 in a malnourished mouse 
model. In addition there is ample evidence that intestinal microbiota affect goblet cell 
dynamics, including mucus secretion and composition either directly by the secretion of 
bioactive factors or indirectly by the activation of host immune cells (Sharma et al., 1995). 
3. The effect of probiotics on the motility of the gastrointestinal tract 
Either gastrointestinal motility or the kinetic of its content is one of the most important 
variations providing gastrointestinal tract’s comfort. The changes in motility can make 
symptoms varying from constipation to diarrhea come into being (Ohashi & Ushida, 2009). 
The interest to probiotics, due to their motility regulatory effects, is rising in functional 
gastrointestinal disorders. 
The influence of microorganisms on intestinal motility was reported for the first time by 
Abraham and Bishop. These researchers observed that both small and large intestinal transit 
time and gastric emptying decreased in germ-free animals (Abraham & Bishop, 1967). 
Husebye et al. (1994) detected that phase-3 intervals in migrating motor complex (MMC) in 
germ-free animals were extended. In addition, they noticed that the motility became normal 
when specific pathogen free bacteria were inoculated in these animals’ intestines. They also 
noticed that the motility of intestines became normal when probiotics were inoculated 
instead of doing so with commensal bacteria. 
Actually gastrointestinal motility and microorganisms in the tracts are mutually influencing 
each other. The presence or the absence of the motility affects microorganisms’ colonization 
and also the motility is being altered in case the microorganisms are lacking. Both migrating 
motor complex in stomach and the one way peristaltic movements in small intestine 
influence the colonization in the area (Quigley, 2011). Thus the decrease of intestinal motility 
causes small intestinal bacterial overgrowth (SIBO).  
In addition to commensal bacteria in gastrointestinal tract, those used as probiotic were also 
detected to be influencing the motility (Williams et al., 2010). Diverse researches related to 
the subject in both human and animal models were conducted. Massi et al. (2006), observed 
in vitro the influence of probiotics on motility in ileum and proximal colon segments isolated 
from guinea pigs. They realized that Lactobacillus and cytoplasmic extract obtained from 
Bifidobacterium caused a contraction in ileum and a relaxation in proximal colon. They 
claimed that the extract mentioned above does not exert its effect via muscarinic receptors 
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since its effect was not inhibited by atropine. Yet, its mechanism is not fully elucidated so far 
(Waller et al., 2011). 
The motility-probiotic relationship in humans was both in healthy individuals and in case of 
different diseases evaluated despite of technical difficulties. Indrio et al. (2008) who 
observed the connection between gastric emptying and the probiotics determined that 
gastric emptying time in infants being given Lactobacillus reuteri was significantly rapid 
compared to those in placebo group. Cherbut et al. (1997) noticed that the motility of 
terminal colon rises while sleeping in humans supplemented with Lactobacillus casei. 
Marteau et al. (2002) reported Bifidobacterium lactus strain DN 173010 to reduce colonic 
transit time in healthy female individuals. Waller et al. (2011) explained that whole gut 
transit time (WGTT) decreased in a dose-dependent manner in male and females obtaining 
different doses of Bifidobacterium lactis HN019 during 14 days.  
Indrio et al. (2009) observing electrical activity that forms motility reported that the 
percentage of propagation (the electric activity turning into peristaltic movement) was 
higher in infants to which Lactobacillus reuteri was given compared to those in placebo 
group. 
Lots of diseases such as irritable bowel syndrome (IBS) causing gastrointestinal dysfunction, 
also influence digestive tract motility or its motor activity. Probiotics are used in treatment 
of motoric function disorders seen in such diseases’ post infective periods. For example post 
infective period hyper contractility was observed to be present in digestive tract of mice 
infected with Trchinella spiralis. It has been observed that the hyper contractility in mice 
given Lactobacillus paracasei NCC2461 specifically weakened (Verdu et al., 2004). In the same 
way delayed gastric emptying was observed in mice infected via Helicobacter pylori. Gastric 
functions were detected to be normalized in the same mice following probiotic treatment 
with  Lactobacillus rhamnosus R0011 and Lactobacillus helvaticus R0052 (Verdu et al., 2008). 
Agrawal et al. (2009) reported that both colonic and orocecal transit were accelerated when 
fermented milk product containing Bifidobactreium lactis DN-173010 were given to patients 
suffering from irritable bowel syndrome presented with abdominal distension and 
constipation and also that this was making the case symptoms’ influences to be diminished. 
Intestinal transit time was detected to be lengthened in diseases representing with digestive 
tract functional disorders such as IBS. Even the mechanism that lies beneath is not fully 
elucidated; it was estimated to be related to the imbalance in intestinal micro flora due to the 
illness itself. 
The effects of probiotics on intestinal tract are being influenced by diverse factors. The 
motility in intestinal tract was acclaimed to be possibly specific to the type of the probiotic 
used (Husebye et al., 2001). Either the physiologic situation of the human or the animal is 
another factor affecting the motility. For example it was detected that in elderly people, 
Bifidobacterium DN 173010 reduces oro-fecal transit time while the same bacteria accelerates 
only colonic transit time in healthy volunteers. In addition, its effects in males were 
established to differ from that in females (Meance et al., 2001). 
3.1 The mechanism of action 
The mechanism lying beneath the effects of probiotics on motility are not fully elucidated. 
Yet the probable influence mechanisms can be divided into three headlines; 1) Products 
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secreted by bacteria or final products formed at the end of fermentation 2) Influence of 
microorganisms on intestinal neuroendocrine factors 3) Influence of mediators secreted due 
to gastrointestinal tract’s immune reaction (Barbara et al., 2005). 
The stimulation of colonic motility via the rise of fecal bacterial mass,  the stimulated 
cholecystokinin and deconjugated or dehydroxylated bile salts is considered to be a part of 
other mechanisms. Some probiotics such as Bifidiobacteium lactis HN019 stimulate the 
production of lactic acid bacteria in the environment. As a consequence of lactic acid 
bacteria production, WGTT time decreases while peristaltic accelerates owing to the 
reduction of the intestinal content pH (Salminen et al., 1997). 
A high number of gas occurring due to the digestion of indigested carbohydrates by colonic 
microbiota influences intestinal motility. Yet different influences may occur in motility 
related to the gas type formed. For example, when methane producing bacteria in intestinal 
flora multiplies, compared to the effects of those releasing hydrogen, intestinal transit time 
increases, motor activity is directly inhibited, and on the contrary  non propulsive and 
segmental contractions increase (Pimentel et al., 2006). 
Short chain fatty acid (SCFA) appearing as an outcome of carbohydrate or lipid 
fermentation by probiotics is one of the most important final products influencing 
gastrointestinal motility. Cherbut et al. (1997) observing the influence of SCFA on motility 
detected that SCFA showed contractile activity via enteric cholinergic reflex in low 
concentrations (0.1 to 10 mmol/L). Nevertheless this was also detected to be a temporary 
effect. SCFA in high concentrations (100 mmol/L) was observed to inhibit colonic 
contraction (Sakata, 1987). McManus et al. (2002) reported that SCFA inhibits peristaltic 
activity while it stimulates the tonic activity in the large intestine of dogs. It exerts this effect 
by influencing Ca+2 influx to gastrointestinal smooth muscle cells. Besides colonic motility 
SCFA was also determined to influence upper part of digestive tract, to cause relaxation in 
both lower esophageal sphincter and proximal stomach and also it decreases gastric 
emptying time. It was explained that it showed this effect via hormonal way with the use of 
polypeptide YY (Labayen et al., 2001). 
In addition, probiotics affect the motility in an indirect way by influencing some 
inflammatory mediators’ expression occurring during the disease that alters gastrointestinal 
tract functions. For example, Lactobacillus paracasei weaken the hyper contractility rising in 
the post infective period of diseases by increasing the expression of COX-2 being one of the 
inflammatory mediators (Verdu et al., 2004). Mediators such as TGF-ǃ and prostaglandin 
E(2) released during gastrointestinal diseases damage both enteric nervous system and 
interstitial cells of cajal. Disorders in the motility occur since the neuronal structures 
mentioned above regulate intestinal tract motility. Probiotics given in post infective period 
normalize the motility as they accelerate the healing of damaged cells in enteric nervous 
system (Indrio et al., 2008). 
4. Effects of probiotics on pancreatic digestive enzymes 
There is only limited research on the effects of probiotics on pancreatic digestive enzymes 
such as amylase, lipase, trypsin, chymotrypsin, although there are few publication related to 
effects of probiotics on mucosal digestive enzymes. The relation between microorganisms of 
intestinal tract and pancreatic enzymes has been investigated in some studies using germ-
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free animals. It has been indicated that the bacterial status altered preferentially the exocrine 
pancreatic function. The specific activities of amylase, trypsin and carboxypeptidase-A were 
lower in germ-free than in conventional rats (Lhoste et al., 1996). How microorganisms in 
digestive tract affect secretion of pancreatic enzymes has not been determined. However 
hormones which stimulate enzyme secretion in pancreas such as enteroglucagon, gastrin or 
pancreatic polypeptide have been reported to be lower in germ-free animals compared to 
conventional animals (Goodlad et al., 1989). Decreased pancreatic enzymes in germ-free 
animals may be explained by this report. Moreover the cecal micro flora may also affect the 
pancreas via its metabolites. In fact, SCFA can stimulate amylase release from the rat 
pancreas directly (Ohbo et al., 1996).  
Matur et al. (2007) have been reported that chymotrypsin levels decreased but amylase, 
lipase and trypsin levels did not changed in pancreas of broiler chicks which were 
supplemented with Enterrococcius facium NCIMB10415. In addition, intestinal tract 
enzyme activities were reported to be lower in animals supplemented with probiotics 
than those of control animals in the same study. The researchers have suggested that the 
relevant probiotics may affect the biosynthesis of pancreatic enzymes or their secretion to 
small intestines, although the mechanism underlying this effect has not been fully 
elucidated yet.  
Microorganisms in digestive tract may also affect digestive enzyme activities indirectly. 
Drouault et al. (2002) have reported that Lactobacillus lactis produces lipase and this lipase 
ameliorated steatorrhea in pigs fed on high lipid meal. 
4.1 Probiotic application in diseases related to digestive enzyme deficiencies 
Sucrase deficiency, also known as sucrase-isomaltase deficiency, is the most common 
disaccharidase deficiency in human. It is a genetic disorder and causes to malabsorption of 
sucrose in diet and consequently to accumulation of hydrogen in the colon, swelling, 
diarrhea and abdominal cramps (Rolfe, 2000). Saccharomyces cerevisiae expresses significant 
sucrase and some isomaltase activity, and it has been proposed to improve malabsorption in 
patients with sucrase-isomaltase deficiency (Harms et al., 1987). Similarly Treem et al. (1993) 
have reported that the liquid preparation which is a by-product of the manufacture of 
baker's yeast reduced breath hydrogen excretion in patients with congenital sucrase-
isomaltase deficiency that were given a sucrose load and allowed most patients to consume 
a sucrose-containing diet. 
4.2 Lactase deficiency 
Lactase insufficiency means that the concentration of the lactose cleaving enzyme ǃ-
galactosidase, also called lactase, in the brush border membrane of the mucosa of the small 
intestine is too small. Lactase deficiency is a very common condition characterized with 
lactose malabsorption in the intestinal mucosa. High concentrations of lactase enzyme are 
physiologically present in neonates. In the post weaning period, an irreversible reduction of 
its activity occurs in human (Montalto et al., 2006), and in mammalian animal species 
(Batchelor et al., 2011). Secondary lactase deficiency can be seen any condition that damages 
the small intestinal epithelial cells or significantly increases the gastrointestinal transit time. 
Thus, secondary hypolactasia is transient and reversible (Montalto et al., 2006).  
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It has been observed that patients with lactose maldigestion had higher lactose tolerance 
when eating fermented dairy products such as yogurt and could easily digest them 
compared to milk. There are two mechanisms lying beneath this situation. First, ǃ-
galactosidase is released from bacteria in yogurt after digested by bile acids. Second, 
delaying gastric emptying and slowing intestinal transit times prolong the action of residual 
ǃ-galactosidase in the small intestine and decrease the osmotic load of the lactose (Marteau 
et al., 2001). Ojetti et al. (2010) were investigated hydrogen breath excretion and 
gastrointestinal symptoms as indicators of lactose intolerance in patients. They have 
reported that hydrogen excretion decreased and clinical symptoms improved in the group 
given Lactobacillus reuteri compared to those of placebo group. De Vrese et al. (2001) tested 
whether live bacteria in the fermented or non-fermented milk product are a prerequisite for 
enhanced lactose cleavage by microbial ǃ-galactosidase. They found that lactose digestion in 
lactose malabsorbers and gastrointestinal well-being can be significantly improved if a milk 
product contains active microbial ǃ-galactosidase. The bacteria need not to be alive but 
intact cell walls are required to act as a mechanical protection of the enzyme during gastric 
passage. 
5. The effect of probiotics on the absorptive function of the intestine 
5.1 Sodium and chloride absorptions 
It has been determined that two carrier proteins play a role in the sodium absorption; 
“sodium hydrogen exchanger-2” (NHE-2) and NHE-3 which are the members of “solute 
carrier family-9” (SLC9) (Malakooti et al., 2011). While NHE-2 is expressed mostly in colon, 
NHE-3 is expressed mainly in ileum (Dudeja et al., 1996). The carrier proteins “down 
regulated in adenoma” (DRA) and putative anion transporter-1 (PAT-1) from SLC26 gene 
family have a role in chloride absorption. While PAT-1 is mainly expressed in small 
intestines, DRA is more expressed in colon than small intestines (Wang et al., 2002).  
Probiotics such as Lactobacillus are used as a treatment support in diseases especially 
characterized by fluid loss in children. It has been determined that probiotics reduce sodium 
chloride and fluid loss in these diseases (Raheja et al., 2010). Furthermore it has been 
reported that Saccharomyces boulardii increases chloride net absorption from jejunum and 
descending colon in vitro (Krammer & Karbash, 1993). 
To investigate the molecular mechanisms underlying the effects of probiotics on electrolyte 
and water absorption from intestinal tract, some in vivo and in vitro studies have been 
carried on. Human colon adenocarcinoma cell (Caco-2) has been used extensively as a 
model cell in vitro experiments subjected intestinal epithelium. Borthakur et al. (2008) 
reported that DRA activity increased in Caco-2 cells after short term Lactobacillus acidophilus 
application and this will cause chloride absorption eventually. Lactobacillus acidophilus was 
reported to cause this effect by increasing DRA expression in apical membranes of epithelial 
cells. However, it has been determined that total DRA amount in the cell did not changed, 
only DRA expression on the surface increased and this effect was caused via phosphatidyl- 
inositol 3-kinase pathway. It has been also considered that some soluble substances secreted 
by Lactobacillus acidophilus revealed this effect. 
Bacteria present in the intestines are consistently interacting with epithelial cells. Therefore, 
it has been determined that, while Lactobacillus acidophilus increase DRA mRNA expression 
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in epithelial cells of colon by transcriptional mechanisms, it is not effective in jejunum and 
ileum during its long-term applications. DRA is primary chloride transporter in colon, 
therefore significance of probiotics in chloride and water absorption has been proved 
(Binder & Mehta, 1989; Raheja et al., 2009). There is a limited knowledge on the molecular 
mechanisms underlying the effects of probiotics on sodium absorption. It is well known that 
probiotics produce short chain fatty acids. The short chain fatty acids increase the 
expression of NHE-3 which plays a main role in the absorption of sodium from ileum (Kiela 
et al., 2007).  
5.2 Na
+
-coupled glucose absorption 
Glucose is absorbed from intestinal brush border membrane by mainly sodium-dependent 
glucose co-transporters 1 (SGLT-1) and glucose transporter 2 (GLUT-2) (Shimizu et al., 
2000). Absorption rate of the intestinal glucose depends on the SGLT-1 affinity and density 
in the membrane. High affinity SGLT-1 is primary transporter for glucose absorption.  
It has been reported that sodium coupled glucose absorption increased in small intestines of 
pigs treated with Saccharomyces boulardii or Bacillus cereus var. toyoi (Breves et al., 2000). It has 
been also determined that Enterococcus faecium NCIMB 10415 used as a probiotic caused an 
increase in intestinal transport and barrier function and glucose absorption (Lodeman et al., 
2006). Similarly, sodium coupled D-glucose absorption increase has been reported in rats 
orally applied Saccharomyces boulardii (Buts et al., 1999).  
The mechanism underlying the sodium coupled glucose absorption increasing effect of 
probiotics in intestinal epithelium cells has not been fully defined. However it has been 
suggested that specific and non-specific mechanisms may be effective. It may be a non-
specific reason such as an increase in the absorptive surface or in affinity of transporters to 
substrates due to probiotics. On the other hand Rooj et al. (2010) have reported that 
supernatant obtained from lactobacilli increased the glucose transport in Caco-2 cells non-
genomically and undefined metabolites produced by the probiotic caused this effect. This 
researchers have suggested that the metabolites produced by the probiotic cause to 
expression of cytosolic transporters in brush border membranes of enterocytes or to 
activation of transporters which were already in the membrane.  
Although it has been suggested that probiotics affect intestinal glucose transport by non-
genomic responses, SGLT-1 expression increases in rats applied Saccharomyces boulardii 
(Buts, 2009). Therefore, it is considered that the probiotics may be effective by changing gene 
expression via transcriptional or post translational mechanisms.  
5.3 Calcium absorption 
It has been reported that probiotics increase the calcium absorption from intestinal tract. 
However mechanisms underlying the increasing absorption are not fully elucidated and 
more than one mechanism may be considered (Gilman et al., 2006). Fermentation products 
occurred as a result of probiotics’ activity may increase the absorption surface by 
accelerating proliferation in enterocytes (Scholz-Ahrens at al., 2007). Furthermore short 
chained fatty acids and the other products produced by the bacteria decrease the pH of 
intestines microenvironment. Therefore, calcium solubility increases and this may be related 
to increased calcium absorption (Gilman et al., 2006; Scholz-Ahrens at al., 2007). Tang et al. 
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(2007) reported that fermenting calcium-fortified soymilk with some Lactobacillus species can 
potentially enhance the calcium bioavailability. 
Brassart & Yey (1998) have determined that 7 Lactobacillus species, which were tested in 
vitro, increased the transepithelial calcium transport in Caco-2 monolayer cells. Gilman & 
Cashman (2006) have reported that the transepithelial calcium transport did not change in 
Caco-2 monolayer cells treated by Lactobacillus salivatorius (UCC 118) and Bifidobacterium 
infantis (UCC 35624), however UCC 118 increased calcium uptake after 24 hours. Although 
the differences between the results of these studies have not exactly clarified, it has been 
suggested that the differences may be due to the different adheration of used bacteria to 
epithelial cells (Gilman & Cashman, 2006). Intestinal calcium absorption increasing effect of 
probiotics may be also related to increased expression of calcium channels in intestinal 
mucosa. Vinderola et al. (2007) observed that supernatant from milk fermented by 
Lactobacillus helveticus R389 enhanced expression of TRPV6 channels in the duodenum. 
Enhanced expression Ca+2 channels indicate an improved capacity for dietary Ca+2 uptake. 
5.4 The effects of probiotics on cholesterol absorption 
Cholesterol entered the body via food or re-absorbed from the bile secretion to the blood, is 
primary factor for heart and vascular diseases. Hypercholesterolemia is one of the most 
significant risk factor for the cardio-vascular diseases. It has been determined that various 
probiotic species decrease the serum cholesterol levels in human (Larkin et al., 2009), 
experimental animals (Park et al., 2007) or farm animals (Özcan et al., 2003; Strompfova et 
al., 2006). However hypocholesterolemic effect of probiotics depends on the species of the 
bacteria. This hypocholesterolemic effect has been suggested to be caused by more than one 
mechanism. For example lactic acid bacteria exert hypocholesterolemic effect by assimilating 
endogenous or exogenous originated cholesterol in intestinal tract or deconjugating bile 
acids (Gilliland et al., 1990). In addition, it has been reported that cholesterol and free bile 
acids bound to the cellular surface of microorganism or co-precipitate with free bile acids by 
probiotics (Guo & Zhang, 2010).  
The recent researches have revealed that probiotics affect gene expression of carrier proteins 
which are responsible for cholesterol absorption. The protein called Niemann-Pick C1-like 1 
(NPC1L1) which is abundantly expressed on the surface of enterocytes, plays a key role on 
the absorption of cholesterol from intestines. Reduction or inhibition of expression levels of 
this protein leads to a decrease in plasma cholesterol levels. The probiotic Lactobacillus 
acidophilus (American type culture collection) ATCC 4356 reduced NPCIL-1 gene expression 
and inhibited the cellular uptake of micellar cholesterol in Caco-2 cells. Soluble effector 
molecules secreted by ATCC 4356 were shown to be responsible for the decrease in NPC1L-
1. Furthermore, ATCC 4356 mediated this effect partly through the liver X receptors (LXR) 
(Huang & Zheng, 2010).  
6. Probiotics and enteric nervous system 
Enteric nervous system (ENS), which is located in the wall of the digestive tract, is a neural 
network called as second brain that is consisted of sensory neurons, motor neurons, inter 
neurons and glial cells. It regulates complicated reflexes, motility and secretory functions of 
digestive tract. Although it is connected to central nervous system, ENS can regulate the 
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function of its target organ without input from the central nervous system (CNS) (Gershon, 
2005).  
There is a mutual communication between CNS and microorganisms in the digestive tract. 
The central nervous system affects microorganisms by chancing motility, secretion, and 
permeability of digestive tract or via various mediators that are secreted by neuro-endocrine 
cells (Barbara et al., 2005). Microorganisms in the digestive tract affect functions of ENS and 
CNS via direct or indirect mechanisms. Microorganisms both affect development of sensory 
and motor neurons and induce plasticity.  
Microorganisms in intestines communicate with nervous system via epithelial cells, various 
receptors or cells in lamina propria. Enterochromaffin cells play a key role in this 
communication. They function such as a transducer and provide a link between intestinal 
lumen and ENS (Indrio & Neu, 2011).  
Effects of microorganisms in intestinal tract on nervous system occur via more than one 
mechanism. They affect development of sensory and motor neurons in gut by secreted 
substances or fermented products. For example SCFA, which is a fermented product of 
microorganisms in digestive tract, may affect motor activity in digestive tract (Soret et al., 
2010). Furthermore, certain mediators secreted by immune cells which are activated by 
microorganisms in intestinal tract are effective on the regulation of ENS. Because, enteric 
neurons have receptors which are responsive to immune cells secreted mediators. For 
example, secretion of substances such as histamine, interleukin-6, leukotrienes, 5-
hydroxytryptamine, platelet activating factor, mast cell proteases, adenosine, interleukin-1ǃ, 
prostaglandins as a result of stimulation of mast cells affect functions of ENS by connecting 
to the receptors on the neurons of ENS (Wood, 2007). 
Bacteria including probiotics can be considered as a chemical factory producing biologically 
active substance such as neurotransmitters and neuromodulators (Wang et al., 2010). It has 
been determined that Lactobacillus and Bifidobacterium produce GABA, Escherichia, Bacillus 
and Saccharomyces produce norepinephrine, Candida, Streptococcus, Escherichia and 
Enterococcus produce serotonin, Bacillus produce dopamine, Lactobacillus produce 
acetylcholine (Lyt, 2011). 
It has been determined that Lactobacillus reuteri increases the excitability of myenteric AH 
cells in rats by inhibiting calcium dependent potassium channels (Kunze et al., 2009). The 
same researches have also reported that activity of ENS was inhibited as a result of the effect 
of Lactobacillus reuteri on AH cells (Whang et al., 2010). Because ENS depresses intestines 
motility, inhibition of ENS causes an increase in motility.  
Probiotics reveal their effects by changing neuro-chemical characteristics of enteric neurons. 
Kamm et al. (2004) have reported that the numbers of neurons containing calbidin, which is 
a multiple calcium binding protein, decreased in jejunum of pigs supplemented with 
Sacharomyces boulardii. Similarly Giancamillo et al. (2010) have reported that the density of 
galaninergic and calcitonin gene-related peptide (CGRP) positive neurons increased in 
submucosal plexus of ileum of Pediococcus acidilactici treated pigs. Galanin is effective on 
peristaltic activity, secretion, blood flow and eating behaviors, and CGRP is effective on the 
modulation of sensory functions and the regulation of activity of smooth muscle. 
Furthermore, the same researchers have determined that density of glial cells in ileums’ 
inner and outer sub mucosal plexus was increased in Pediococcus acidilactici treated pigs.  
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Probiotics have been used in the treatments of neuromotoric and sensory functional 
disorders of digestive tract since their effects on ENS have been revealed. For example, it has 
been reported that functional disorders such as delayed gastric emptying, increased visceral 
perception and abnormal feeding pattern which occurs in mice due to Helikobacter infection, 
were treated by supplementation of Lactobacillus rhamnosus R0011 and Lactobacillus helveticus 
R0052 (Verdu et al., 2008). 
Probiotics in digestive tract affect central nervous system by both ENS and parasympathetic 
fibers that innervates digestive tract. However this effect is probably species specific. For 
example, Lactobacillus reuteri changes mRNA expressions of GABAA and GABAB receptors 
in central nervous system. The changes in these receptors have found to be related with 
anxious and depressive-like behaviors (Cryan & O’Mahony, 2011). Similarly it has been 
reported that Bifidobacterium longum has anxiolytic effect and decreases the excitability of 
ENS (Bercik et al., 2011). 
7. The effect of probiotics on the intestinal barrier functions 
Intestinal barrier is a morphologic and physiologic structure placed between tissues and 
intestinal lumen which is known as external environment and it ensures continuing of 
events such as absorption and secretion between them. Intestinal lumen consists of 
microclimate on epithelial cells and lamina propria under epithelium. It regulates nutrients 
absorption, water and ion fluxes, and represents the first defensive barrier against toxins 
and enteric pathogens. Intestinal barrier consists of internal and external layers; the internal 
layer includes intestinal epithelial cells and tight junctions (TJ), the external layer includes 
bacteria and a mucus layer (Catalioto et al., 2011). 
The intestinal epithelium is formed by a monolayer epithelial cells, the spaces between 
epithelial cells is sealed by tight junctions. Tight junctions are specific structures comprised 
of transmembrane proteins. Microclimate consists of unstirred water layer, glycocalyx, and 
mucus layer. Lamina propria is a layer existed under epithelial cells. In this layer there are 
cells of innate and acquired immunity secreting immunoglobulins and cytokines which are 
substantial for intestinal barrier.  
Proper intestinal barrier function is essential for maintaining optimal health and balance 
throughout the body. The epithelium of the intestinal mucosa prevents the passage of 
commensal and pathogenic microorganisms. Therefore, it is the first line of defense against 
luminal antigens and toxins. An impairment of this intestinal barrier is critical for 
pathogenesis of several diseases such as inflammatory bowel disease, celiac disease 
(Chichlowski et al., 2008) and atopic dermatitis (Rosenfeldt et al., 2004). 
Development of physical and functional intestinal barrier begins during embryonic 
period. In human, enterocytes appear in intestinal mucosa at 8th weeks, and TJ appear at 
10th weeks of pregnancy. Functional immune barrier becomes functional after the 
formation of panet cells at 12th weeks. In this period, panet cells produce antimicrobial 
defensins and lysozymes. Mucins, which start to be expressed at 6.5th weeks of pregnancy 
and increase in time, constitute functional barrier. Although the development of intestinal 
barrier begins at prenatal period, it continues through postnatal period (Patel & Lin, 
2010). Because, intestinal barrier is not yet fully developed in preterm infants, aberrant 
inflammatory and apoptotic responses to bacteria may occur. When premature infants 
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treated with probiotics, bacteria used as probiotic easily pass lamina propria and trigger 
immune reaction there. 
It has been determined by in vivo and in vitro studies that probiotics strengthen intestinal 
barrier. This effect occurs through species specific various mechanisms. These mechanisms 
are the inhibition of apoptosis of epithelial cells, the regulation of TJ proteins expression and 
the distribution, prevention of attachments of pathogens to mucosa, and the regulation of 
mucus secretion.  
7.1 Tight junction protein expression 
The intestinal bacteria or probiotics change the expression and distribution of TJ proteins 
(Mennigen & Bruewe, 2009). Several studies investigated the effects of different probiotics 
on TJ protein expression and distribution under pathological conditions. Occludin is an 
integral plasma-membrane protein located at the TJs. Zonula occludens-1 (ZO-1) is a 
peripheral membrane protein and it is found to be associated with the cytoplasmic surfaces 
of TJs (Gottardi et al., 1996). Probiotic bacteria Streptococcus thermophilus and Lactobacillus 
acidophilus prevent the reduction in phosphorylation of occludin and zonula occludens-1 
(ZO-1) caused by enteroinvasive Escherichia coli (EIEC) infection (Resta-Lenert & Barrett, 
2003). Re-distribution of ZO-1 protein has been observed after epithelial cells were treated 
by a pathologic bacterium Salmonella dublin. However, treatment of epithelial cells with 
multi-microbe probiotic product VSL#3 prevented the redistribution of ZO-1 (Ng et al., 
2009). 
7.2 Epithelial adherence and pathogen exclusion 
Many intestinal bacteria can adhere to the outer mucus layer to form a biofilm on their 
surface (Guarner & Malageda, 2003). This is an important mechanism for intestinal barrier. 
Three different situations in favor of the host and against pathogens should be considered. 
One of them is exclusion of pathogens by probiotics competitively. The second is the 
prevention of pathogen adhesion. And the third is displacement of adhered pathogen. 
Sherman et al. (2005) have reported that Lactobacillus rhamnosus and acidophilus could adhere 
to intestinal epithelial cells in vitro and pre-treatment of these probiotic strains reduced the 
binding of EPEC and EHEC. Additionally, Lactobacillus strains can directly compete with 
other pathogens, such as Salmonella species, for binding sites on human mucins or Caco-2 
cell surfaces. It has been observed that the mentioned probiotics can also displace bound 
pathogens, although more slowly and to a lesser extent (Lee et al., 2003). There is a 
competition between pathogens and probiotics for sources of nutrients as well as a 
competition for adherence to mucosa or displacement from mucosa. This competition is 
useful for exclusion of pathogens and for strengthening intestinal barrier.  
7.3 Mucus secretion 
It has been reported by in vivo and in vitro studies that certain bacteria contribute to 
strengthen mucosal barrier by increasing mucus secretion. Mattar et al. (2002) reported that 
Lactobacillus casei GG increased mucin expression in the human intestinal cell lines Caco-2 
(MUC2) and HT29 (MUC2 and MUC3), thus blocking pathogenic Escherichia coli invasion 
and adherence. Additionally, Otte & Podolsky (2004) observed that VSL#3 increased 
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expression of MUC2, MUC3 in HT29 cells. Probiotics induce this mucus expression 
increasing effect by modifying gene expressions. For example, it has been observed that 
MUC2 and MUC3 mRNA expressions were increased after incubation of epithelial cells 
with Lactobacillus plantarum 299v (Mack et al., 1999). Similarly Caballero-Franco et al. (2007) 
have reported that basal luminal mucin content increased by 60% in Wistar rats that were 
orally administered the probiotic mixture VSL#3 on a daily basis for seven days. In addition, 
they exposed isolated rat colonic loops to the VSL#3 probiotic formula, which significantly 
stimulated colonic mucin (MUC) secretion and MUC2 gene. 
Probiotics also contributes to strengthening of intestinal barrier with some mechanisms 
other than above mentioned ones. For example, Polyphosphate (poly-P) is produced by 
probiotics and it is a bioactive molecule that induced cytoprotective heat shock protein 
through activation of the integrin–p38 mitogen-activated protein kinase pathway, and it 
prevents oxidant-induced intestinal barrier weakening. Furthermore, poly-P ameliorated 
epithelial injury (Segawa et al., 2011). It has been reported that multi-microbe probiotic 
product VSL#3 normalized monolayer permeability and conductance in stimulated tissues, 
thus strengthened barrier integrity (Madsen et al., 2001). It has been determined that 
Lactobacillus rhamnousus GG prevented cytokine induced apoptosis in young adult mouse 
colon cell model (YAMC) and human colonic epithelial carcinoma cell line (HT29) (Yan & 
Polk, 2002).  
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